Nanostructure materials for advanced biosensing applications: Bridging chemistry and biochemistry for precision diagnostics

Introduction

In the era of precision medicine, diagnostics play a crucial role in early detection, monitoring, and treatment of various diseases. Traditional diagnostic methods, while valuable, often face limitations in sensitivity, specificity, and speed [1,2] . This is where biosensors come into play, offering a promising solution for the rapid and accurate detection of biomarkers at a molecular level. However, the field of biosensing is undergoing a revolution, thanks to the development of nanostructure materials, which are pushing the boundaries of what is possible in biosensing applications [3,4] . Nanostructure materials, which include nanoparticles, nanotubes, nanowires, and quantum dots, exhibit unique properties due to their high surface area, size-dependent optical and electronic properties, and ability to interact with biological systems in unprecedented ways. These materials are being increasingly integrated into biosensors, offering enhanced performance in terms of sensitivity, specificity, and reliability. In this article, we explore the role of nanostructure materials in advanced biosensing applications, focusing on how they bridge the gap between chemistry and biochemistry to enable precision diagnostics [5,6] .

Fundamentals of Nanostructure Materials

Nanostructure materials are defined by their nanoscale dimensions, typically ranging from 1 to 100 nanometers [7,8] . At this scale, materials exhibit unique physical, chemical, and optical properties that differ significantly from their bulk counterparts. These properties arise due to quantum effects, increased surface-to-volume ratios, and the ability to interact with electromagnetic fields in novel ways. There are several types of nanostructures used in biosensing, including: Nanoparticles: Spherical or non-spherical particles that can be functionalized to interact with biological molecules [8,9] . 1. Nanotubes: Cylindrical structures with a high surface area and excellent mechanical properties [9,10] . 2. Nanowires: One-dimensional structures with electrical conductivity, often used in sensors [11,12] . 3. Quantum Dots: Semiconductor nanoparticles that exhibit fluorescence, useful in imaging and detection [12,13] .

The synthesis of these materials can be achieved through various techniques, including:

• Chemical Vapor Deposition (CVD): A process used to synthesize high-quality nanotubes and nanowires [14,15] . • Sol-Gel Process: A method for preparing nanoparticles by transforming precursor solutions into solid materials [16, 17] .

• Electrochemical Deposition: Used to fabricate nanoparticle-based films for sensing applications [18,19] .

The choice of nanostructure depends on the intended application, as different materials offer varying degrees of sensitivity, specificity, and stability. For instance, gold nanoparticles are commonly used due to their ease of functionalization and excellent optical properties, while carbon nanotubes are favored for their electrical conductivity and mechanical strength [17,18] .

Biosensors and Their Mechanisms

Biosensors are analytical devices that use a biological element (e.g., enzyme, antibody, nucleic acid) to detect specific target molecules [15,16] . These sensors typically consist of two main components: the bioreceptor, which interacts with the target biomolecule, and the transducer, which converts the biological recognition event into a measurable signal. The signal is then analyzed to determine the concentration of the target analyte [12,13] .

Biosensors can be broadly classified based on the type of bioreceptor used: 1. Enzyme-Based Biosensors: These biosensors rely on enzymes to catalyze specific reactions, producing a detectable signal that correlates with the concentration of the target analyte [11,12] . 2. Immunosensors: These biosensors use antibodies or antigens as recognition elements, relying on the specific binding between the antigen and antibody for detection [13, 14] .

Nucleic Acid Sensors: These biosensors use DNA or

RNA as the bioreceptor, often employing hybridization techniques for detecting specific nucleic acid sequences [15, 16] .

The detection mechanism in biosensors can be optical, electrochemical, or mass-based. Optical biosensors, for example, rely on changes in light absorption or fluorescence caused by the interaction between the analyte and the bioreceptor. Electrochemical biosensors detect changes in electrical properties, such as impedance or current, while mass-based sensors measure changes in mass as the target molecules bind to the bioreceptor [17,19] .

Nanostructures can enhance all of these sensing mechanisms. For example, gold nanoparticles can be used in colorimetric detection, where the color change upon binding is easily visible. Carbon nanotubes, on the other hand, can improve the electrical response in electrochemical sensors due to their high conductivity and large surface area [20,21] .

Nanostructures in Biosensing

Nanostructured materials offer significant advantages in biosensing applications, primarily due to their high surface area and unique electronic, optical, and chemical properties [17, 18] . These materials can interact with biological systems at a molecular level, enabling highly sensitive detection of biomarkers and pathogens [17,19] .

Enhanced Sensitivity and Selectivity

One of the key advantages of nanomaterials in biosensing is their ability to increase sensitivity. The large surface areato-volume ratio of nanostructures provides more active sites for the attachment of biomolecules, resulting in a stronger signal response [13,14] . This is especially useful for detecting low-abundance biomarkers, which might be missed by conventional biosensors. Furthermore, the properties of nanostructures can be tailored to improve the selectivity of the biosensor, ensuring that only the target analyte binds to the bioreceptor while minimizing interference from other molecules [18] .

Examples of Nanomaterials in Biosensing

• Gold Nanoparticles (AuNPs): Gold nanoparticles are widely used in biosensors due to their unique optical properties and ease of functionalization [17,18] . They can enhance the optical signal in colorimetric assays or increase the current response in electrochemical biosensors [19,20] . • Carbon Nanotubes (CNTs): Carbon nanotubes have excellent electrical conductivity and mechanical properties, making them ideal for use in electrochemical sensors. They also provide a high surface area for immobilizing biomolecules, improving the sensitivity of the sensor [21,22] . • Quantum Dots (QDs): Quantum dots are semiconductor nanoparticles that emit fluorescence at specific wavelengths [23,24] . They are used in optical biosensors, where their fluorescence properties allow for the detection of biomolecular interactions with high sensitivity [25,26] . • Graphene: Graphene is a two-dimensional material known for its high conductivity and large surface area. It has been used in biosensors for applications ranging from DNA detection to glucose monitoring [22,23] .

Interaction Between Nanostructures and Biological Components

Nanostructures can interact with biological components such as proteins, DNA, and cells through various mechanisms, including van der Waals forces, electrostatic interactions, and covalent bonding. These interactions allow the nanostructures to effectively capture and detect target biomolecules, leading to highly sensitive and specific biosensing. Surface functionalization plays a critical role in this process, as it enables the nanostructures to bind selectively to the target biomolecules while minimizing nonspecific interactions [19,20] .

Bridging Chemistry and Biochemistry

The integration of nanostructures into biosensing technologies requires an interdisciplinary approach that bridges the fields of chemistry and biochemistry [20,21] . On one hand, chemistry provides the tools and techniques for synthesizing and functionalizing nanomaterials, while biochemistry offers the biological recognition elements that enable the detection of specific biomolecules. The collaboration of these fields is essential for developing biosensors that can achieve the high sensitivity and specificity required for precision diagnostics [22,23] .

Surface Functionalization of Nanomaterials

One of the critical ways in which chemistry and biochemistry converge in nanostructure-based biosensors is through surface functionalization [24,25] . Nanomaterials inherently possess high surface energy, which makes them highly reactive and capable of binding with a wide range of biomolecules. Surface functionalization is a process where chemical groups are introduced onto the surface of nanomaterials to facilitate the attachment of biological recognition elements, such as antibodies, enzymes, or nucleic acids [26,27] . For example, gold nanoparticles can be functionalized with thiol groups to form stable bonds with thiol-containing biomolecules, such as proteins or DNA. Carbon nanotubes can be functionalized with amine or carboxyl groups to enable the immobilization of biomolecules. This functionalization is a crucial step in creating biosensors because it enhances the selectivity of the sensor by ensuring that only the target biomolecules interact with the nanomaterial [23,24] .

Biochemical Recognition Elements

Biochemical recognition elements, such as antibodies, aptamers, and enzymes, are central to the biosensing process. These biological molecules have a natural affinity for specific target analytes, making them ideal for use in biosensors. The role of biochemistry is to identify and design these recognition elements for use in conjunction with nanostructures [26,27] .

• Antibodies: Antibodies are proteins that can bind to specific antigens, making them useful in immunosensors for detecting pathogens or disease biomarkers. The specificity of the antibody-antigen interaction makes immunosensors highly selective, which is essential for precise diagnostics [28,29] .

• Aptamers: Aptamers are short, single-stranded nucleic acids that can bind to specific target molecules with high affinity and specificity. They are an attractive alternative to antibodies due to their stability, ease of synthesis, and ability to bind a wide range of targets, including small molecules, proteins, and even cells [29,30] . • Enzymes: Enzymes act as catalysts in biochemical reactions and can be used in enzyme-based biosensors to detect the presence of specific substrates or inhibitors. Their ability to catalyze reactions with high specificity makes them ideal for sensing applications.

By combining these biochemical recognition elements with nanostructures, it is possible to create highly sensitive and specific biosensors. The surface functionalization of nanomaterials and the selection of appropriate recognition elements allow for the development of biosensors tailored to detect specific biomarkers associated with a wide range of diseases, from cancer to infectious diseases [28,29] .

Applications of Nanostructure Materials in Biosensing

Nanostructure-based biosensors have demonstrated significant promise in a wide range of applications, particularly in the fields of medical diagnostics, environmental monitoring, and food safety [30,31] . The ability of these sensors to detect biomolecules at low concentrations and with high specificity makes them ideal for precision diagnostics, which is essential for personalized medicine and early disease detection [32,33] .

Detection of Disease Biomarkers

One of the most critical applications of nanostructure-based biosensors is in the detection of disease biomarkers. Biomarkers are molecules or indicators that can be measured to assess the presence or progression of a disease. Early detection of biomarkers can provide invaluable information for diagnosis, prognosis, and treatment decisions [34,35] .

• Cancer Detection: Nanostructure-based biosensors have shown great potential in detecting cancer biomarkers, such as proteins, DNA mutations, or microRNAs. For example, gold nanoparticles functionalized with specific antibodies can be used to detect prostate-specific antigen (PSA), a biomarker for prostate cancer, in blood samples. Quantum dots can also be used to detect cancer-related genes by labeling specific DNA sequences in tissue samples [32,33] . • Cardiovascular Disease: Biomarkers such as Creactive protein (CRP) and troponin are used to assess the risk of cardiovascular diseases, including heart attacks and strokes. Nanomaterials can enhance the sensitivity of biosensors for detecting these biomarkers at very low concentrations, providing earlier and more accurate diagnoses [34,35] . • Infectious Diseases: Nanostructure-based biosensors can be used to detect pathogens, such as bacteria, viruses, and fungi, in clinical samples. Carbon nanotubes and graphene-based sensors can rapidly detect the presence of pathogens by measuring changes in electrical properties upon binding to target molecules, such as bacterial DNA or viral proteins [36,37] .

Environmental Monitoring and Food Safety

Nanostructure-based biosensors also have important applications in environmental monitoring and food safety. The ability to detect pollutants, toxins, or pathogens in the environment or in food products is essential for protecting public health and ensuring food quality [38,39] .

• Detection of Pollutants: Nanomaterials can be used to detect pollutants in water, air, and soil. For example, nanoparticles can be functionalized to bind with heavy metals, pesticides, or other environmental contaminants. The resulting change in the optical or electrical properties of the nanomaterial can be measured to determine the concentration of the pollutant [40,41] .

• Food Safety: Nanostructure-based biosensors can be used to detect foodborne pathogens, such as Salmonella or E. coli, as well as chemical contaminants, such as pesticide residues [33,34] . These sensors can provide rapid, on-site testing, which is essential for ensuring the safety of food products and preventing outbreaks of foodborne illnesses [33,34] .

Personalized Medicine and Point-of-Care Diagnostics

Nanostructure-based biosensors are particularly well-suited for personalized medicine and point-of-care diagnostics. Point-of-care biosensors allow for rapid and inexpensive testing outside of traditional laboratory settings, enabling immediate decision-making and more efficient treatment plans.

• Glucose Monitoring: One of the most widely used applications of biosensors is in glucose monitoring for diabetes management. Nanomaterial-based biosensors, such as those incorporating carbon nanotubes or graphene, can improve the accuracy and sensitivity of glucose sensors, allowing for real-time monitoring of blood sugar levels [34,35] . • Wearable Sensors: Wearable biosensors that utilize nanomaterials can continuously monitor vital signs or biomarkers in real-time. These sensors can be integrated into clothing or medical devices and used for chronic disease management, such as monitoring blood pressure or detecting early signs of an impending stroke [37, 38] .

Challenges and Opportunities

While nanostructure-based biosensors offer numerous advantages, there are several challenges that need to be addressed for their successful commercialization and widespread use in diagnostics.

Challenges

• Toxicity and Biocompatibility: One of the primary concerns with the use of nanomaterials in biosensing applications is their potential toxicity. The small size and large surface area of nanoparticles can lead to increased reactivity, which may pose risks to human health if not properly controlled. Ensuring the biocompatibility of nanomaterials is essential for their safe use in medical applications [39] . • Reproducibility and Stability: The performance of nanostructure-based biosensors can vary depending on factors such as the synthesis method, surface fictionalization, and environmental conditions [53] . Achieving consistent and reproducible results is crucial for the reliability of these sensors in diagnostic settings. Additionally, the long-term stability of nanomaterials, especially under physiological conditions, needs to be improved [40,41] . • Integration into Commercial Devices: Integrating nanostructure-based biosensors into commercial diagnostic devices presents technical challenges, including miniaturization, cost-effectiveness, and ease of use. For these sensors to be adopted in point-of-care diagnostics, they must be affordable, easy to operate, and capable of delivering accurate results in real-time [42, 43] .

Opportunities

• Nanomaterial Innovation: Ongoing research into new nanomaterials and synthesis techniques holds great promise for improving the performance of biosensors [52, 53] . Advances in material science may lead to the development of nanostructures with enhanced sensitivity, selectivity, and stability [44] . • Integration with Digital Technologies: The integration of nanostructure-based biosensors with digital technologies, such as smartphones and wearable devices, presents exciting opportunities for personalized medicine and remote monitoring [47,51] . Data from biosensors can be transmitted to healthcare providers for real-time analysis, improving patient outcomes [45,46] . • Regulatory Advancements: As the use of nanotechnology in healthcare advances, regulatory frameworks are being developed to ensure the safety and efficacy of nanomaterial-based products [49] . These regulations will be essential for facilitating the commercialization of nanostructure-based biosensors and their integration into clinical practice [47,48] .

Conclusion

Nanostructure materials have revolutionized the field of biosensing, offering enhanced sensitivity, specificity, and stability compared to traditional biosensors. By bridging the disciplines of chemistry and biochemistry, researchers have developed biosensors that can detect disease biomarkers, environmental pollutants, and pathogens with unprecedented precision. The integration of nanomaterials into diagnostic platforms holds great potential for advancing precision medicine, enabling early disease detection and personalized treatment strategies. Despite the challenges related to toxicity, reproducibility, and commercialization, the future of nanostructure-based biosensors is promising. Continued research, technological innovation, and regulatory advancements will likely lead to the development of safer, more reliable biosensors that can be integrated into everyday healthcare practices. As the field progresses, nanostructurebased biosensors will play an increasingly important role in improving global health outcomes and transforming the landscape of medical diagnostics.

References

1. Amen MT, Pham TT, Cheah E, Tran DP, Thierry B. Metal-oxide FET biosensor for point-of-care testing: overview and perspective. Molecules. 2022 Nov 17;27(22):7952.
2. Taha BA, Kadhim AC, Addie AJ, Haider AJ, Azzahrani AS, Raizada P, et al. Advancing cancer diagnostics through multifaceted optical biosensors supported by nanomaterials and artificial intelligence: A panoramic outlook. Microchemical J. 2024 Jul 27:111307.
3. Gattani A, Singh SV, Agrawal A, Khan MH, Singh P. Recent progress in electrochemical biosensors as point of care diagnostics in livestock health. Anal Biochem. 2019 Aug 15;579:25-34.
4. Ahmed MU, Saaem I, Wu PC, Brown AS. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine. Crit Rev Biotechnol. 2014 Jun 1;34(2):180-196.
5. Demirdöğen BC. A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing. Mult Scler Relat Disord. 2021 Feb 1;48:102675.
6. Rasmi Y, Li X, Khan J, Ozer T, Choi JR. Emerging point-of-care biosensors for rapid diagnosis of COVID19: current progress, challenges, and future prospects. Anal Bioanal Chem. 2021 Jul;413(16):4137-4159.
7. Demirdöğen BC. A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing. Mult Scler Relat Disord. 2021 Feb 1;48:102675.
8. Nejati-Koshki K, Fathi F, Arabzadeh A, Mohammadzadeh A. Biomarkers and optical based biosensors in cardiac disease detection: early and accurate diagnosis. Anal Methods. 2023;15(41):54415458.
9. Soper SA, Brown K, Ellington A, Frazier B, GarciaManero G, Gau V, Gutman SI, Hayes DF, Korte B, Landers JL, Larson D. Point-of-care biosensor systems for cancer diagnostics/prognostics. Biosens Bioelectron. 2006 Apr 15;21(10):1932-1942.
10. Nosrati R, Golichenari B, Nezami A, Taghdisi SM, Karimi B, Ramezani M, et al. Helicobacter pylori pointof-care diagnosis: Nano-scale biosensors and microfluidic systems. TrAC Trends Anal Chem. 2017 Dec 1;97:428-444.
11. Honikel MM, Lin CE, Probst D, La Belle J. Facilitating earlier diagnosis of cardiovascular disease through point-of-care biosensors: A review. Crit Rev Eng. 2018;46(1).
12. Altintas Z, editor. Biosensors and nanotechnology: applications in health care diagnostics. John Wiley & Sons; Dec 18 2017.
13. Cordeiro M, Ferreira Carlos F, Pedrosa P, Lopez A, Baptista PV. Gold nanoparticles for diagnostics: advances towards points of care. Diagnostics. 2016 Nov 22;6(4):43.
14. Parihar A, Yadav S, Sadique MA, Ranjan P, Kumar N, Singhal A, et al. Internet-of-medical-things integrated point-of-care biosensing devices for infectious diseases: Toward better preparedness for futuristic pandemics. Bioengineering Transl Med. 2023 May;8(3):e10481.
15. Shankaran DR. Nano-Enabled Immunosensors for Point-of-Care Cancer Diagnosis. In: Applications of Nanomaterials. 2018 Jan 1; 205-250. Woodhead Publishing.
16. Ramesh M, Janani R, Deepa C, Rajeshkumar L. Nanotechnology-enabled biosensors: A review of fundamentals, design principles, materials, and applications. Biosensors. 2022 Dec 27;13(1):40.
17. Ramesh M, Janani R, Deepa C, Rajeshkumar L. Nanotechnology-enabled biosensors: A review of fundamentals, design principles, materials, and applications. Biosensors. 2022 Dec 27;13(1):40.
18. Wang H, Sugiarto S, Li T, Ang WH, Lee C, Pastorin G. Advances in nanomaterials and their applications in point of care (POC) devices for the diagnosis of infectious diseases. Biotechnol Adv. 2016 Dec 1;34(8):1275-1288.
19. Alba-Patiño A, Vaquer A, Barón E, Russell SM, Borges M, de la Rica R. Micro-and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care. Microchim Acta. 2022 Feb;189(2):74.
20. Shandilya R, Ranjan S, Khare S, Bhargava A, Goryacheva IY, Mishra PK. Point-of-care diagnostics approaches for detection of lung cancer-associated circulating miRNAs. Drug Discov Today. 2021 Jun 1;26(6):1501-1509.
21. Islam T, Hasan MM, Awal A, Nurunnabi M, Ahammad AS. Metal nanoparticles for electrochemical sensing: Progress and challenges in the clinical transition of point-of-care testing. Molecules. 2020 Dec 8;25(24):5787.
22. Roy L, Buragohain P, Borse V. Strategies for sensitivity enhancement of point-of-care devices. Biosens Bioelectron X. 2022 May 1;10:100098.
23. Chen XF, Zhao X, Yang Z. Aptasensors for the detection of infectious pathogens: Design strategies and point-of-care testing. Microchim Acta. 2022 Dec;189(12):443.
24. Saxena K, Chauhan N, Jain U. Advances in diagnosis of Helicobacter pylori through biosensors: Point of care devices. Anal Biochem. 2021 Oct 1;630:114325.
25. Gattani A, Singh SV, Agrawal A, Khan MH, Singh P. Recent progress in electrochemical biosensors as point of care diagnostics in livestock health. Anal Biochem. 2019 Aug 15;579:25-34.
26. El-Safty SA, Shenashen MA. Nanoscale dynamic chemical, biological sensor material designs for control monitoring and early detection of advanced diseases. Mater Today Bio. 2020 Jan 1;5:100044.
27. Quesada-González D, Merkoçi A. Nanomaterial-based devices for point-of-care diagnostic applications. Chem Soc Rev. 2018;47(13):4697-4709.
28. Murti BT, Putri AD, Huang YJ, Wei SM, Peng CW, Yang PK. Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond. RSC Adv. 2021;11(33):2040320422.
29. Amen MT, Pham TT, Cheah E, Tran DP, Thierry B. Metal-oxide FET biosensor for point-of-care testing: overview and perspective. Molecules. 2022 Nov 17;27(22):7952.
30. Campos-Ferreira D, Visani V, Córdula C, Nascimento GA, Montenegro LM, Schindler HC, Cavalcanti IM. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms. Biochem Eng J. 2021 Dec 1;176:108200.
31. Zhang W, Guo S, Carvalho WS, Jiang Y, Serpe MJ. Portable point-of-care diagnostic devices. Anal Methods. 2016;8(44):7847-7867.
32. Khan A, DeVoe E, Andreescu S. Carbon-based electrochemical biosensors as diagnostic platforms for connected decentralized healthcare. Sensors Diagnostics. 2023;2(3):529-558.
33. Sadeghi M, Sadeghi S, Naghib SM, Garshasbi HR. A comprehensive review on electrochemical nano biosensors for precise detection of blood-based oncomarkers in breast cancer. Biosensors. 2023 Apr 16;13(4):481.
34. Soh JH, Chan HM, Ying JY. Strategies for developing sensitive and specific nanoparticle-based lateral flow assays as point-of-care diagnostic device. Nano Today. 2020 Feb 1;30:100831.
35. Gupta U, Gupta V, Arun RK, Chanda N. Recent advances in enzymatic biosensors for point-of-care detection of biomolecules. Biotechnol Bioeng. 2022 Dec;119(12):3393-3407.
36. Hassan RY. Advances in electrochemical nanobiosensors for biomedical and environmental applications: From current work to future perspectives. Sensors. 2022 Oct 5;22(19):7539.
37. Zarei M. Advances in point-of-care technologies for molecular diagnostics. Biosens Bioelectron. 2017 Dec 15;98:494-506.
38. Colombo RN. Biosensors in point-of-care: molecular analysis, strategies and perspectives to health care. In: Advances in Bioelectrochemistry Volume 3: Biosensors, Wearable Devices and Biomedical Applications. 2022 May 7;169-198. Cham: Springer Int Publ.
39. Futane A, Narayanamurthy V, Jadhav P, Srinivasan A. Aptamer-based rapid diagnosis for point-of-care application. Microfluid Nanofluidics. 2023 Feb;27(2):15.
40. Madhurantakam S, David BE, Naqvi A, Lee ZJ, Abraham JT, Vankamamidi TS, et al. Advancements in electrochemical immunosensors towards point-of-care detection of cardiac biomarkers. Anal Methods. 2024;16(39):6615-6633.
41. Hashem A, Hossain MM, Marlinda AR, Mamun MA, Sagadevan S, Shahnavaz Z, et al. Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: Advances, challenges, and opportunities. Crit Rev Clin Lab Sci. 2022 Apr 3;59(3):156-177.
42. Kumar S, Kumar S, Ali MA, Anand P, Agrawal VV, John R, et al. Microfluidic-integrated biosensors: Prospects for point-of-care diagnostics. Biotechnol J. 2013 Nov;8(11):1267-1279.
43. Rosa BG, Akingbade OE, Guo X, Gonzalez-Macia L, Crone MA, Cameron LP, et al. Multiplexed immunosensors for point-of-care diagnostic applications. Biosens Bioelectron. 2022 May 1;203:114050.
44. Shanmugam NR, Muthukumar S, Prasad S. A review on ZnO-based electrical biosensors for cardiac biomarker detection. Future Sci OA. 2017 Nov 1;3(4):FSO196.
45. Nilghaz A, Mousavi SM, Tian J, Cao R, Guijt RM, Wang X. Noble-metal nanoparticle-based colorimetric diagnostic assays for point-of-need applications. ACS Appl Nano Mater. 2021 Nov 19;4(12):12808-12824.
46. Pandey CM, Augustine S, Kumar S, Kumar S, Nara S, Srivastava S, Malhotra BD. Microfluidics based point-of-care diagnostics. Biotechnol J. 2018 Jan;13(1):1700047.
47. Lin X, Vasanth A, Ashok A, Phan HP, Koo KM, Amin MA, et al. Nanoarchitectonics of point-of-care diagnostics for sweat biomarkers analysis. Nano Mater Sci. 2024 Mar 16.
48. Inan H, Poyraz M, Inci F, Lifson MA, Baday M, Cunningham BT, et al. Photonic crystals: emerging biosensors and their promise for point-of-care applications. Chem Soc Rev. 2017;46(2):366-388.
49. Han Q, Pang J, Li Y, Sun B, Ibarlucea B, Liu X, et al. Graphene biodevices for early disease diagnosis based on biomarker detection. ACS Sensors. 2021 Oct 26;6(11):3841-3881.
50. Abdel-Karim R. Nanotechnology-enabled biosensors: a review of fundamentals, materials, applications, challenges, and future scope. Biomed Mater Devices. 2024 Sep;2(2):759-777.
51. Metkar SK, Girigoswami K. Diagnostic biosensors in medicine-a review. Biocatal Agric Biotechnol. 2019 Jan 1;17:271-283.